|Haruhisa Inoue M.D., Ph.D.|
Molecular-biological analyses are advancing our understanding of intractable neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), but radical care is still to be established. This laboratory aims to perform basic scientific research for further understanding of the disease mechanisms using patient-specific iPS cells, with the perspective of translating the findings into developing methods of treatment and/or prevention of the diseases.
|iPS cells derived from ALS (Amyotrophic Lateral Sclerosis) patients
|Inclusion body in ALS spinal motor neuron
Credit: Dr. Hidefumi Ito, Department of Neurology, Wakayama Medical University